:: 13 Nov 2008 ::
Patents Issue for Inotek Pharmaceuticals’ Lead Clinical Candidates in Glaucoma and Contrast-Induced Nephropathy
:: read full press release ::

:: 1 Oct 2008 ::
Inotek Appoints Paul G. Howes as President and CEO
:: read full press release ::

:: 18 Jun 2008 ::
Inotek Commences Phase 1 Trial in Glaucoma with Selective Adenosine 1 (A1) Agonist
:: read full press release ::